Hector D. Ceccoli, M.D., F.A.C.C.

2000 – present: Invasive Cardiologist, Crockett, Texas; East Texas Medical Center; Practice includes diagnostic coronary and peripheral vascular angiography; Nuclear cardiology, pacemaker implant and follow-up, TEE
2001 – 2004: Director, Mobile Cardiac Catheterization Laboratory, East Texas Regional Medical System
2000 – 2003: Emergency Medicine Physician, East Texas Medical Center Trinity, Texas
2000 – 2003: Cardiovascular Associates of East Texas, Crockett, Texas
1995 – 1996: Chief Resident and Instructor in Clinical Medicine, University of Illinois at Chicago

Post-Graduate Training and Medical Education

1996 – 1999: Cardiology Fellowship, University of Illinois at Chicago
1992 – 1996: Internal Medicine Residency, University of Illinois at Chicago
1983 – 1990: Medical School, Universidad Nacional de Rosario, Rosario, Santa Fe, Argentina

Certification and Professional Organizations

2005: President, Houston County Medical Society
1999: Diplomate, Subspecialty Board of Cardiovascular Disease
1996: Diplomate, American Board of Internal Medicine
2000: Advanced Life Support (ACLS, PAL, ATLS)
1992: Federation Licensing Examination (FLEX)
1992: Foreign Medical Graduate Examination in Medical Sciences (FMGEMS)

Hospital Appointments

2005- Present: Acting Staff - Trinity Mother Frances Hospital, Tyler, Texas
2005 – Present: Acting Staff - East Texas Medical Center Hospital, Tyler, Texas

Research

Primary Investigator – OPTIMUM Registry - A prospective, outcome-oriented registry of patients implanted with SJM OptimTM leads. This registry evaluated the chronic performance of the market-released SJM Cardiac Rhythm Management (CRM) leads with OptimTM insulation material.
Co-Investigator – RE-LY Study - Randomized Evaluation of Long term anticoagulant therapy (RE-LY) comparing the efficacy and safety of two blinded doses of dabigatran etexilate with open label warfarin for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: prospective, multi-centre, parallel-group, non-inferiority trial.
Co-Investigator – ENDEAVOR IV – A Randomized, Controlled Trial of the Medtronic Endeavor Drug Eluting Coronary Stent System versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions.
Investigator – TRENDS - A prospective, non-randomized, multi-center trial in subjects implanted with a commercially available Medtronic implantable pulse generator (IPG), implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) device. The primary purpose of the trial is to determine if the device trending data are indicators of clinical outcomes in subjects with atrial tachyarrhythmias.
Co-Investigator – OMNI Study - Post-market observational study conducted in the United states. The purpose of the OMNI study is to characterize therapy and diagnostic utilization in study participants implanted with study devices and to describe ICD therapy utilization for life threatening arrhythmias in primary and secondary prevention study participants.
Co-Investigator - ULTRA study- Ventricular Automatic Capture assessment Study.
Co-Investigator - XIENCE™ V: Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study sponsored by Abbott Vascular Inc.

Publications

Tsai, H., Ceccoli, H., Avitall, B., Ono K., Hosaka, H., and He, B., Clinical Application of body surface Laplacian Mapping in Diagnosis of Myocardial Infarction, Bioengineering Program &EECS Department, University of Illinois at Chicago. Proceedings of the Annual International Conference of IEEE Engineering in Medicine and Biology Society, 48-50, 1998.
Tsai, H., Ceccoli, H., Avitall, B., Ono K., Hosaka, H., and He, B, Body Surface Laplacian Mapping of Chronic Myocardial Infarction, Bioengineering Program &EECS Department, University of Illinois at Chicago. Proceedings of the Annual International Conference of Electromagnetics in Medicine, 1997.
Tsai, H., Wu, D., Ceccoli, H., Avitall, B., Ono K., Hosaka H., and He, B., Localization of Chronic Myocardial Infarction by Means of Body Surface Laplacian Mapping, Proceedings of Computers in Cardiology, accepted for publication.